Business Context and Reporting Period
This Form 6-K filing by Can-Fite Biopharma Ltd. covers the month of April 2020, with the report dated April 27, 2020. The filing serves to notify shareholders of a change in the schedule for a Special Meeting of Shareholders.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice regarding a shareholder meeting and does not contain financial statements or performance data.
Material Changes
There are no material financial changes reported in this filing. The only material event is the rescheduling of the Special Meeting of Shareholders, originally adjourned to April 28, 2020, at 4:00 p.m. Israel time, and subsequently reconvened for April 28, 2020, at 10:00 a.m. Israel time due to a temporary nationwide quarantine in Israel ahead of Independence Day.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding business operations. The primary risk or contingency noted is the impact of the nationwide quarantine in Israel, which necessitated the change in the meeting time.
Key Facts for Investor Verification
- The Special Meeting of Shareholders is scheduled for April 28, 2020, at 10:00 a.m. Israel time.
- The meeting location is the Company's offices at 10 Bareket Street, Petach Tikva, Israel.
- The time change was driven by a temporary nationwide quarantine in Israel.
- This filing does not contain financial results or operational updates.